Clinical Trial Update: A Phase II Study of Utidelone With Toripalimab in Advanced Cervical Cancer [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating utidelone in combination with toripalimab for advanced cervical cancer is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Toripalimab (Toripalimab)
• Utidelone (utidelone)

Snippet

Sponsor: Zhongnan Hospital | Conditions: Cervical Cancer, Recurrent | Phase 2 | Status: NOT_YET_RECRUITING